Approval · Notice of Compliance 35351 · 2025
LIBRAX: Notice of Compliance 35351
Issued May 15, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35351
- Date
- May 15, 2025
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replacement or Addition of a manufacturing site and/or manufacturer involving production of the starting material.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LIBRAX | Not yet assigned | — |
Medicinal ingredients
- CHLORDIAZEPOXIDE HCL 5 MG per CAP
- CLIDINIUM BROMIDE 2.5 MG per CAP